Clinical Trial: Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954259) titled 'Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy' on April 24.

Brief Summary: Evaluate the prognostic correlation between the neutrophil ratio and the ratio of CD4+/CD8+ T cells in patients with advanced non-small cell lung cancer (NSCLC) who receive immunotherapy combined with chemotherapy, with the aim of providing references for clinical treatment.

Study Start Date: July 01, 2022

Study Type: OBSERVATIONAL

Condition: NSCLC (Advanced Non-small Cell Lung Cancer)

Recruitm...